Robert Schmidt

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Tyco International Plc engages in the provision of security products and services, fire detection and suppression products and services, and life safety products. It operates through the following segments: North America Integrated Solutions and Services (NA Integrated Solutions and Services), Rest of World (ROW) Integrated Solutions and Services (ROW Integrated Solutions and Services), and Global Products. The NA Integrated Solutions and Services segment designs, sells, installs, services and monitors integrated electronic security systems and integrated fire detection and suppression systems for commercial, industrial, retail, small business, institutional and governmental customers in North America. The ROW Integrated Solutions and Services segment designs, sells, installs, services and monitors integrated electronic security systems and integrated fire detection and suppression systems for commercial, industrial, retail, residential, small business, institutional and governmental customers in the ROW regions. The Global Products segment designs, manufactures and sells fire protection, security and life safety products, including intrusion security, anti-theft devices, breathing apparatus and access control and video management systems, for commercial, industrial, retail, residential, small business, institutional and governmental customers worldwide. The company was founded on 1960 and is headquartered in Albert Quay, Ireland.